In summary, our investigation suggests that the epigenetic regulator UHRF1 is involved in the progression of B-ALL by modulating the WNT5A–P38 MAPK–HK2 signaling axis, which mediates the glycolytic pathway. The gene discussed is HK2; the disease is precursor B-cell acute lymphoblastic leukemia.